Great summary @ryan1986 and @ozelectro you've covered everything discussed - it was a quick meeting. Would just reiterate that it was raised that current ASX backlog might delay anticipated re-listing, which wasn't related to any fundamental change.
This wouldn't affect US strategy as they had always planned for mid year 2016 US launch. Punitive measures for legislation will only take effect towards end calendar year, and hospitals need to be showing they're taking steps to address legislative requirements,and then adding to those/scaling up CDSS changes.
They also made a point to mention that the US wasn't the only market they're focussing on next year..
NRR Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
